Ultralife Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $187.9M-6.5% YoYTTM through 31 Mar 2026
Net Income -$8.2MTTM through 31 Mar 2026
Margins
| Current | |
|---|---|
| Gross Margin | 21.3% |
| Operating Margin | -0.4% |
| Net Margin | -1.0% |
Returns
-0.3%ROE
-0.2%ROA
Balance Sheet Health
Debt / Equity0.37x
Current Ratio2.56x
Net Debt$38.7M
Cash & Equivalents$8.9M
Quality Metrics
Earnings-Beat Rate0.0%
Dividend
No dividend
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.